The United States Should Stand by Argentina’s Milei U.S. Senator Marco Rubio (R-FL) December 11, 2023 Medium President Joe Biden should welcome [Javier Milei’s inauguration as president of Argentina] because friends are hard to come by in Latin America right now. The...
EE.UU. debería apoyar al presidente electo Milei 10 de diciembre del 2023 La Nación …Milei es un aliado y EE.UU. debería apoyarlo. El presidente Joe Biden debería darle la bienvenida a Milei porque en estos momentos es difícil encontrar aliados en Latinoamérica y el...
The Biden Administration has been slow to implement sanctions under the Uyghur Human Rights Policy Act, which became law in 2020, and seeks to hold the perpetrators of the Uyghur genocide accountable. U.S. Senator Marco Rubio (R-FL) and U.S. Representative Mike...
In-person Mobile Office Hours Monday, December 11, 2023 Jackson County 9:30am – 11:00am CST UF/IFAS Jackson County Extension 2741 Penn Ave. Suite 3 Marianna, FL 32448 Click Here Pinellas County 1:30pm – 3:00pm EST Pinellas Park Chamber of Commerce 5851 Park...
Foreign adversaries, including China, have significantly increased covert tactics to infiltrate American colleges and K-12 schools. They do this to steal research, spread propaganda, and silence students and academics. U.S. Senator Marco Rubio (R-FL) and...
The criminal Maduro regime issued bogus warrants to arrest members of the Venezuelan opposition, including several campaign staffers working for opposition leader María Corina Machado, who won the opposition’s primary election earlier this year. Last night, Roberto...
China is targeting America’s biomed industry
By U.S. Senator Marco Rubio
September 21, 2019
Modern Healthcare
Time after time, Americans have watched our nation’s leaders—in politics, academia and the private sector—invest in and open our markets to China with little concern for long-term consequences. When it comes to the threat China poses to the U.S. healthcare industry, we cannot afford to be complacent.
While consumers may have initially welcomed the influx of inexpensive Chinese goods, such as generic drugs and antibiotics, the ultimate price is paid by U.S. manufacturers, who are undercut by China’s cheap labor and forced to shutter. Beijing will continue to undermine America’s withering industries by blatantly stealing our companies’ intellectual property and subsidizing state firms to undercut our competitive edge. China’s goal is market dominance.
…
If we fail to prevent Chinese genomic dominance, how might the future look? Our dependence on Beijing for antibiotics and other drugs, recently flagged by the Pentagon, is instructive. The Chinese have used their command in the pharmaceutical industry as a bargaining chip in tariff negotiations. As the sole makers of some of our military’s drugs, they wield an additional source of leverage in the case of future conflict.
If you find yourself in a hole, the first step is to stop digging. We must immediately enact stricter guidelines for federal policies to guarantee that public funding never contributes to Chinese genomics efforts and then ensure our R&D in this critical area is not eclipsed by China. I have written to HHS’ OIG to voice concerns and submitted several National Defense Authorization Act amendments to this end. I am also developing a unified strategy to protect Americans’ genomic data. Beijing blocks its citizens’ DNA from being shared or stored outside China because they know the data’s value. Why don’t we consider similar measures to prevent others from benefiting from Americans’ DNA?
Chinese domination of the genomics industry poses an extraordinary danger to Americans; medical professionals, healthcare executives and policymakers alike must recognize the extent of the threat. Failure to do so will put our nation’s well-being at risk.
Read more here.